Galafold and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Galafold (migalastat hydrochloride), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Oxycodone, and have Fabry's disease.

The phase IV clinical study analyzes which people have Stroke when taking Galafold. It is created by eHealthMe based on reports of 442 people who have side effects when taking Galafold from the FDA, and is updated regularly.

What is Galafold?

Galafold has active ingredients of migalastat hydrochloride. eHealthMe is studying from 442 Galafold users. Check the latest studies of Galafold.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,355 drugs and 3,022 conditions by eHealthMe. Check the latest studies of Stroke.

On Jan, 18, 2026

442 people reported to have side effects when taking Galafold.
Among them, 30 people (6.79%) have Stroke.

Among these 30 people:

How long have people been on Galafold when they have Stroke? *

What is the gender of people who have Stroke when taking Galafold? *

female: 40 %
male: 60 %

What is the age of people who have Stroke when taking Galafold? *

What are other drugs people take besides Galafold? *

What are other side effects people have besides Stroke? *

Impaired Work Ability: 7 people, 23.33%
Pain: 7 people, 23.33%
Depression: 7 people, 23.33%
Device Related Infection: 7 people, 23.33%
Fainting (loss of consciousness and postural tone): 7 people, 23.33%
Flatulence (flatus expelled through the anus): 7 people, 23.33%
Loss Of Consciousness: 7 people, 23.33%
Adverse Event: 7 people, 23.33%
Rhinorrhea (watery mucus discharge from the nose): 7 people, 23.33%
Poor Quality Sleep: 6 people, 20.00%

What are the existing conditions these people have? *

Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 28 people, 93.33%
Pain: 8 people, 26.67%
Heart Disease: 7 people, 23.33%
Depression: 4 people, 13.33%
Dysmenorrhea (painful menstruation): 3 people, 10.00%
Lipidosis (disorder of lipid metabolism involving abnormal accumulation of lipids in the reticuloendothelial cells): 1 person, 3.33%
Chest Pain: 1 person, 3.33%
Asthma: 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Galafold and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Galafold:

Galafold (442 reports)

Stroke treatments and more:

Stroke (334,634 reports)

Browse all side effects of Galafold:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,355 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,022 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on migalastat hydrochloride (the active ingredients of Galafold) and Galafold (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.